Trials / Withdrawn
WithdrawnNCT01986049
Transversus Abdominis Plane (TAP) Block for Post Caesarian Pain
Phase 3 Study Comparing Transversus Abdominis Plane Block After Caesarian Section Usin Bupivacaine 0.5% vs. Bupivacaine 0.25% vs. Placebo (Normal Saline).
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- New York Presbyterian Brooklyn Methodist Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Adding TAP block with Bupivacaine may decrease the use of PCA bolus use after caesarean section for pain relief.
Detailed description
Participants in the study will be randomized to TAP block with 0.5% or 0.25% bupivacaine or with placebo (normal saline). The number of PCA bolus used within 24 hours post cesarean section will be compared between the groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivicaine |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2013-11-18
- Last updated
- 2021-10-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01986049. Inclusion in this directory is not an endorsement.